ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,918.25
0.00%
Dow Jones
42,635.20
0.00%
US Dollar vs MXN
20.49036
0.36%
Brent Oil
76.875
1.16%
Bitcoin
92,714.88
-2.46%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Alemania
  5. TG

  6. Newron Pharmaceuticals Spa. (NP5) Cotización

Newron Pharmaceuticals Spa.

Newron Pharmaceuticals Spa. (NP5)

TG
9.35
-0.03
( -0.32% )
Actualizado: 12:13:16
Realtime Data

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
9.35
Postura de Compra
9.25
Postura de Venta
9.40
Volume Operado de la Acción
13,689
9.03 Rango del Día 10.54
6.65 Rango de 52 semanas 13.50
Capitalización de Mercado [m]
166.854M
Precio Anterior
9.38
Precio de Apertura
10.54
Hora
200
@
9.35
Última hora de negociación
12:11:25
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
7,405
Acciones en circulación
17,845,345
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-10.30
Beneficio por acción (BPA)
-0.91
turnover
9.06M
Beneficio neto
-16.22M

Acerca de Newron Pharmaceuticals Spa.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.newron.com
Sede
Milan, Lombardy, Ita
Fundado
-
Newron Pharmaceuticals Spa. is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NP5. The last closing price for Newron Pharmaceuticals was 9.38 €. Over the last year, Newron Pharmaceuticals shares have traded in a share price range of 6.65 € to 13.50 €.

Newron Pharmaceuticals currently has 17,845,345 shares in issue. The market capitalisation of Newron Pharmaceuticals is 167.39 € million. Newron Pharmaceuticals has a price to earnings ratio (PE ratio) of -10.30.

NP5 Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.22-2.298850574719.5710.5399999.029999939479.54479271DE
40.9511.30952380958.413.57.9151129.38056833DE
120.8610.12956419328.4913.57.2274058.93145007DE
261.070000112.92270667788.279999913.57.2257928.64529173DE
521.722.22222222227.6513.56.65101159.1474889DE
1567.87531.7567567571.4813.51.1363187.34757551DE
2602.944.96124031016.4513.51.1345086.68260077DE

NP5 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Newron Pharmaceuticals?
El precio actual de las acciones de Newron Pharmaceuticals es 9.35 €
¿Cuántas acciones de Newron Pharmaceuticals están en circulación?
Newron Pharmaceuticals tiene 17,845,345 acciones en circulación
¿Cuál es la capitalización de mercado de Newron Pharmaceuticals?
La capitalización de mercado de Newron Pharmaceuticals es EUR 167.39M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Newron Pharmaceuticals?
Newron Pharmaceuticals ha negociado en un rango de 6.65 € a 13.50 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Newron Pharmaceuticals?
El ratio precio/beneficio de Newron Pharmaceuticals es -10.3
¿Cuál es el ratio de efectivo a ventas de Newron Pharmaceuticals?
El ratio de efectivo a ventas de Newron Pharmaceuticals es 18.44
¿Cuál es la moneda de reporte de Newron Pharmaceuticals?
Newron Pharmaceuticals presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Newron Pharmaceuticals?
El último ingresos anual de Newron Pharmaceuticals es EUR 9.06M
¿Cuál es el último beneficio anual de Newron Pharmaceuticals?
El último beneficio anual de Newron Pharmaceuticals es EUR -16.22M
¿Cuál es la dirección registrada de Newron Pharmaceuticals?
La dirección registrada de Newron Pharmaceuticals es VIA ANTONIO MEUCCI 3, BRESSO, MILAN, LOMBARDY, 20091
¿Cuál es la dirección del sitio web de Newron Pharmaceuticals?
La dirección del sitio web de Newron Pharmaceuticals es www.newron.com
¿En qué sector industrial opera Newron Pharmaceuticals?
Newron Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
GTYGateway Real Estate AG
1.40 €
(186.89%)
936.29k
DBVDBV Technologies
1.28 €
(70.67%)
21.43k
PBS0Precision Biosciences Inc
6.30 €
(43.18%)
5.64k
2OZAMicrovast Holdings Inc
2.535 €
(40.21%)
334.98k
6L6Senseonics Holdings Inc
0.5642 €
(36.02%)
22.86k
QP9Atco Mining Inc
0.0032 €
(-73.33%)
30k
E3O1Nexoptic Technology Corp
0.0095 €
(-44.12%)
22.48k
CNWCodon AG
0.007 €
(-36.36%)
25
H5EHelma Eigenheimbau Ag
0.055 €
(-31.25%)
1.04k
L09Lithium Energi Exploration Inc
0.0155 €
(-31.11%)
47k
PF8European Lithium Limited
0.0328 €
(9.33%)
4.53M
D7GNel ASA
0.2522 €
(1.41%)
2.82M
LHADeutsche Lufthansa AG
5.614 €
(-4.69%)
2.58M
QJ4Auric Minerals Corp
2.2995 €
(-13.96%)
2.47M
G7PAEnergy Transition Minerals Ltd
0.0466 €
(-2.92%)
1.75M

Discusión

Ver feed completo
havnagoodtime havnagoodtime 31 segundos hace
Yes, right here >>

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175485449
HMBL
sylvia07 sylvia07 37 segundos hace
Thats what happens when you are greedy!
DBMM
Goteleft Goteleft 39 segundos hace
Not very good at math either I see.
UNVC
underpar71 underpar71 40 segundos hace
There is no valid reason that the MTD ruling should take 7 months! Why does everything with NWBO take 10 times longer.
NWBO
chino98 chino98 1 minuto hace
Anyone think we'll touch back down to $2.00? Or we thinking we're steady here? 
XRPUSD
PickStocks PickStocks 1 minuto hace
Sure...it will be in your accounts soon....real soon....get those financial advisors big money from Libor could be billions........
COOP
Involuntary-Recluse Involuntary-Recluse 1 minuto hace
Sounds great T.
I miss skiing. Did it for 5 years hardcore between 1981-86. Went to practically every ski hill in Vermont, New Hampshire, New York, Quebec, and Maine.(Possibly Massachusetts, i don't recall 😂)

Then life took over and never got back into it, but replaced
RickNagra RickNagra 2 minutos hace
$153.48 on deck.

https://valueinvesting.io/FNMA/valuation/intrinsic-value
FNMA
Elroy Jetson Elroy Jetson 2 minutos hace
Runyon Canyon fire is extinguished, not buildings harmed, just the usual low-intensity burnout of the scrubby park plants evolved to survive fires.

Santa Ana winds gone with gusts up to 6 mph
ORCA ORCA 3 minutos hace
Q1 US DUE JANUARY 15TH=NEXT WEDS.PENNY MARKET ON FIRE.LETS HOPE RJDG.SEES .014 T0 AS HIGH AS .03 IN 2025.IF VOLUMES COME IN,AND WE HAVE SOME GOOD EARNINGS REPORT,ALL IS POSSIBLE.
RJDG
Konaploinks Konaploinks 4 minutos hace
From what I’ve been searching around and reading is that Jensen has not retracted or cleaned up his comment. The latest sentiment I’m getting is that he made it in defense of his GPU’s in all the data centers that could be threatened in a few short years or sooner by the latest advancements in quant
IONQ
236T568 236T568 4 minutos hace
How cool is this

https://x.com/reesejgorman/status/1877386631482671579
jog49 jog49 4 minutos hace
So whose idea is that . . . . DJT? I think NOT.
DJT
chxal chxal 4 minutos hace
As far as I am concerned, the CEO's of any company's most important function is to CREATE SHAREHOLDER VALUE, period, end of story. Priscilla could have been more shareholder friendly by emphasizing that the legacy stockholders stand to gain bigly from her efforts to improve profitability at Fannie.
FNMA
Slim6 Slim6 5 minutos hace
Quantum computing companies down more than 50% this week.
Most companies are still more than 250% of reasonable valuation. This still includes quantum computing companies.
Terrible overvaluation. S&P 500 CAPE P/E ratio should be about 15. Even if overvalued, it should be no more than
SP500
powerwalker powerwalker 5 minutos hace
Is there a connection between this article in A&D and the peer review paper that needs to be emphasized?

Also, has the peer review paper received a published date in the JPAD ... and I do not mean 1 January 2025?
AVXL
richme richme 5 minutos hace
All you need to do is turn 70 then spend all your money before a computer watching your hard earned money go down the tubes. Will that work?
If it goes over a $ many will stay for $2. I will be hard pressed not to sell my shares at .50 or at least half of them, then wait for the $ and higher
MONI
here2help here2help 5 minutos hace
Johnny please stickie this guy's post, thanks.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175631904
IDVV
otcsource otcsource 6 minutos hace
If this is not trading by OB then this one very well may have some major explaining to do!! no longer seems like a simple fix! IMO
TWOH
TightCoil TightCoil 6 minutos hace
Even before we go to the bathroom?
FNMA
BDEZ BDEZ 6 minutos hace
Yangwang???
dewophile dewophile 7 minutos hace
You lucked out on RVNC most lost money there - that is an example of a distressed buyout for sure. I have one example where I lost money despite a buyout and that was ZGEN. Sure I made back some paper losses, but net net was a loss. Can't win them all
RVNC
Monksdream Monksdream 8 minutos hace
Stoke Therapeutics (STOK)

Medical technology network team meeting concept. Doctor hand working smart phone modern digital tablet laptop computer graphics chart interface, sun flare effect photo, PTE
Source: everything possible / Shutterstock.com

Focused on addres
STOK
Slim6 Slim6 9 minutos hace
QUBT is down more than 50% over this week. Most companies are still more than 250% of reasonable valuation. This includes quantum computing companies.
Terrible overvaluation. S&P 500 CAPE P/E ratio should be about 15. Even if overvalued, it should be no more than 18.
But right now, it
QUBT SPI

Su Consulta Reciente

TG
NP5
Newron Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados